Red Light Therapy for Muscle Growth: How to Read the Evidence

Red light therapy is the consumer-facing name most often used for photobiomodulation (PBM). Panels, lamps, and handheld devices are promoted to lifters for recovery, soreness, performance, and muscle growth.

The most defensible answer is not “it works” or “it is useless.” PBM has some controlled exercise evidence, but studies are small and technically varied, and a short-term performance result does not establish a larger muscle after a training block.

Recovery is not the same as growth

Researchers measure several outcomes that marketing pages often blend together:

• repetitions or time to fatigue in one session;
• perceived soreness or recovery;
• force or one-repetition maximum;
• blood markers such as creatine kinase; and
• muscle thickness or lean mass over time.

An intervention can change one of these outcomes without changing hypertrophy. For muscle growth, the relevant question is whether a well-controlled, sufficiently long resistance-training study shows a meaningful additional adaptation—not whether light changes a mechanism or makes one workout feel different.

What current reviews suggest

A 2025 meta-analysis of 12 studies in 346 young adults found a small pooled benefit for the maximum number of repetitions after PBM compared with placebo. The analysis also found no clear difference between laser and LED subgroups, with confidence intervals that included no effect for each subgroup.

That is evidence of a possible acute exercise effect, not a licence to promise that any red panel will improve muscle growth. Protocols, body sites, devices, and timing varied across the studies.

Longer-term evidence is less convincing. A 2026 review of PBM added to resistance training in older adults found no statistically significant improvement in maximal strength versus sham PBM in its prespecified meta-analysis. A 2024 scoping review described possible improvements in some muscle and functional outcomes, but it also showed how different the protocols and populations are.

Why consumer comparisons are difficult

“Red light” is not a dose. A device's output depends on wavelength, irradiance at the skin, treatment distance, area, contact, duration, and calibration. A product listing may state a nominal wavelength without showing the dose that reaches the target tissue.

Do not assume that:

• a larger panel is more effective;
• a higher power is better;
• a specific wavelength range guarantees deeper or faster results;
• five minutes or a particular weekly frequency is evidence-based for your device; or
• a laser and an LED panel are interchangeable in every setting.

The most honest consumer decision is to treat the effect as uncertain and potentially small. If a device is expensive, compare it with the value of ordinary training, food, sleep, and a recovery plan you will actually follow.

A cautious trial, if you choose to try it

Keep the experiment simple:

1. Record a stable baseline for repetitions, load, session RPE, soreness, and sleep.
2. Follow the manufacturer's instructions and do not change several recovery tools at once.
3. Keep exercises, rest intervals, and progression rules as consistent as practical.
4. Review trends over repeated sessions rather than treating one good workout as proof.
5. Stop if the device causes discomfort or skin or eye symptoms, and seek clinical advice for medical use.

Do not use PBM to train through acute pain, mask an injury, or postpone an assessment for a persistent problem.

The bottom line

Red light therapy may offer a small, context-dependent acute exercise benefit, but the current evidence does not establish a reliable muscle-growth effect or a universal home-device protocol. It is an optional experiment, not a foundation of hypertrophy programming.

Applying this article

If you try a device, record a stable baseline, change no other recovery tool, follow the device instructions, and review repeated-session performance or soreness. Stop for adverse symptoms and do not use light to delay assessment of an injury or medical condition.

Related reading

• Photobiomodulation for Lifters: What Low-Level Light Studies Actually Show
• Recovery Technologies for Lifters

Limits of the evidence

PBM trials differ in device, dose, timing, muscle group, exercise, population, and outcome. The best current evidence is not a single consumer prescription, and acute repetitions or soreness should not be presented as proof of long-term hypertrophy.

Sources

• Acute effects of photobiomodulation therapy on the maximum number of repetitions in resistance exercise. 2025 systematic review and meta-analysis; acute outcome with heterogeneous protocols.
• Photobiomodulation as an adjunct to resistance exercises among older adults. 2024 scoping review of varied resistance-exercise protocols.
• Photobiomodulation as an adjunct to resistance training in older adults. 2026 systematic review and meta-analysis; no clear maximal-strength advantage versus sham.
• Effects of photobiomodulation on pain and return to play of injured athletes. Review of an injured-athlete context; not evidence for general hypertrophy.